Lon Schneider is a Psychiatry physician affiliated with University of Southern California. OpenAlex indexes 512 publications with 58,211 citations (h-index 86); ClinicalTrials.gov lists 8 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1520 San Pablo St
Ste 1652
Los Angeles, CA 900335321
Telephone
323-442-6000Provider last certified this registry record 7 Sept 2020.
Clinical trials
- Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
Sponsor: Neurim Pharmaceuticals Ltd.
- Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
Sponsor: University of Arizona
- Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
Sponsor: University of Arizona
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Global Services, LLCProgram year202510 payments
- Novo Nordisk IncProgram year20256 payments
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
13 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:
- Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
Institute for Molecular Medicine
FY2026$2,115,510R01AG074983 - FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.
Institute for Molecular Medicine
FY2025$5,308,961R01AG092949
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
Rohit Varma, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”